Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
2261por Badger, SA, Brant, JL, Jones, C, McClements, J, Loughrey, MB, Taylor, MA, Diamond, T, McKie, LD“…INTRODUCTION: Pancreatic cancer has a poor prognosis with <5% alive at 5 years, despite active surgical treatment. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Texto -
2262
-
2263por Li, Junhui, Ma, Qingyong, Liu, Han, Guo, Kun, Li, Feng, Li, Wei, Han, Liang, Wang, Fengfei, Wu, Erxi“…BACKGROUND: Patients with higher levels of fasting serum glucose have higher death rates from pancreatic cancer compared to patients with lower levels of fasting serum glucose. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2264“…The PED portal brings together multidimensional pancreatic cancer data from the literature including genomic, proteomic, miRNA and gene expression profiles. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2265
-
2266“…The purpose of this study was to determine the clinical significance of nodal micrometastasis detected by immunohistochemistry in patients that had undergone curative surgery for pancreatic cancer. Between 2005 and 2006, a total of 208 lymph nodes from 48 consecutive patients with pancreatic cancer that had undergone curative resection were immunostained with monoclonal antibody against pan-ck and CK-19. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2267por Barber, Louise J., Rosa Rosa, Juan M., Kozarewa, Iwanka, Fenwick, Kerry, Assiotis, Ioannis, Mitsopoulos, Costas, Sims, David, Hakas, Jarle, Zvelebil, Marketa, Lord, Christopher J., Ashworth, AlanEnlace del recurso
Publicado 2011
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2268“…Pancreatic cancer (PC) has a complex etiology and displays a wide range of cellular escape pathways that allow it to resist different treatment modalities. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2269
-
2270por Baylot, V, Andrieu, C, Katsogiannou, M, Taieb, D, Garcia, S, Giusiano, S, Acunzo, J, Iovanna, J, Gleave, M, Garrido, C, Rocchi, P“…Despite many advances in oncology, almost all patients with pancreatic cancer (PC) die of the disease. Molecularly targeted agents are offering hope for their potential role in helping translate the improved activity of combination chemotherapy into improved survival. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2271por Tahira, Ana C, Kubrusly, Márcia S, Faria, Michele F, Dazzani, Bianca, Fonseca, Rogério S, Maracaja-Coutinho, Vinicius, Verjovski-Almeida, Sergio, Machado, Marcel CC, Reis, Eduardo M“…Thus, improvement in current knowledge of molecular changes associated with pancreatic cancer is urgently needed to explore novel venues of diagnostics and treatment of this dismal disease. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2272“…Pancreatic cancer (PaCa) is a major health concern due to its aggressiveness and early metastasis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2273por Tentes, Antonios-Apostolos K., Kyziridis, Dimitrios, Kakolyris, Stylianos, Pallas, Nicolaos, Zorbas, Georgios, Korakianitis, Odysseas, Mavroudis, Christos, Courcoutsakis, Nicolaos, Prasopoulos, Panos“…Background and Aims. 5-year survival in patients with pancreatic cancer is poor. Surgical resection is the only potentially curative resection. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2274por Sorin, Vladimir, Ohana, Patricia, Gallula, Jennifer, Birman, Tatiana, Matouk, Imad, Hubert, Ayala, Gilon, Michal, Hochberg, Avraham, Czerniak, Abraham“…Pancreatic cancer is the eighth cancer leading cause of cancer-related death in the world and has a 5-year survival rate of 1–4% only. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2275“…Background: Research over the last twenty years has yielded much insight into pancreatic cancer biology, but it has neither improved diagnostics methods nor the way of treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2276“…Pancreatic cancer is a devastating human malignancy and gain of functional mutations in K-ras oncogene is observed in 75%–90% of the patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2277por Kapoor, ShailendraEnlace del recurso
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2278por Deng, Li, Ke, Xingfa, He, Zhiying, Yang, Daoqiu, Gong, Hai, Zhang, Yingying, Jing, Xiaolong, Yao, Jianzhong, Chen, Jianming“…Pancreatic cancer is a highly lethal disease with a 5-year survival rate less than 5% due to the lack of an early diagnosis method and effective therapy. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2279“…BACKGROUND: A major challenge to the development of biomarkers for pancreatic cancer (PC) is the small amount of tissue obtained at the time of diagnosis. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2280“…The aim of the study was to investigate the relationship between pancreatic cancer incidence and selected dietary factors, alcohol consumption, and tobacco smoking in Poland in 1960–2008. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto